Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis S Constine

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
Haematologica|July 14, 2022
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001Deborah M Stephens, Hongli Li, Louis S Constine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapySteven E Lipshultz, David C Landy, Gabriela Lopez-Mitnik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotectionGordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2024
Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary StatementJohn T Lucas, Zachary R Abramson, Katherine Epstein, et al.
Pediatric Blood & Cancer|January 3, 2013
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupLeontien C M Kremer, Renée L Mulder, Kevin C Oeffinger, et al.
Blood|June 28, 2022
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysisAkash Parekh, Frank G Keller, Kathleen M McCarten, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation doseLouis S Constine, Nancy Tarbell, Melissa M Hudson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2012
Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor studyTara O Henderson, Preetha Rajaraman, Marilyn Stovall, et al.
Health Physics|January 1, 2014
Second malignant neoplasms and cardiovascular disease following radiotherapyLois B Travis, Andrea K Ng, James M Allan, et al.
Pediatric Blood & Cancer|October 28, 2016
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology GroupCindy L Schwartz, Lu Chen, Kathleen McCarten, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
Haematologica|July 14, 2022
Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001Deborah M Stephens, Hongli Li, Louis S Constine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapySteven E Lipshultz, David C Landy, Gabriela Lopez-Mitnik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotectionGordon L Phillips, Steven H Bernstein, Jane L Liesveld, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2024
Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary StatementJohn T Lucas, Zachary R Abramson, Katherine Epstein, et al.
Pediatric Blood & Cancer|January 3, 2013
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization GroupLeontien C M Kremer, Renée L Mulder, Kevin C Oeffinger, et al.
Blood|June 28, 2022
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysisAkash Parekh, Frank G Keller, Kathleen M McCarten, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation doseLouis S Constine, Nancy Tarbell, Melissa M Hudson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2012
Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor studyTara O Henderson, Preetha Rajaraman, Marilyn Stovall, et al.
Health Physics|January 1, 2014
Second malignant neoplasms and cardiovascular disease following radiotherapyLois B Travis, Andrea K Ng, James M Allan, et al.
Pediatric Blood & Cancer|October 28, 2016
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology GroupCindy L Schwartz, Lu Chen, Kathleen McCarten, et al.
Pageof 23